Profile data is unavailable for this security.
About the company
Shilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), formulation and development service. It is engaged in APIs, intermediates, formulations, new drug delivery systems, peptides / biotech products and specialty chemicals, and others. The Company supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Pemetrexed, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various international markets including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-Oncology API products include Ambroxol (Mucolytic agent), Tranexmic Acid and Ursodeoxycholic Acid. Its Injectable Dosage Forms include Myelodysplastic Syndrome, Breast Cancer, Multiple Myeloma, and more. Its Oral Solid Dosage Forms include Psoriasis, Prostate Cancer, Multiple Sclerosis, and others.
- Revenue in INR (TTM)14.32bn
- Net income in INR1.50bn
- Incorporated1987
- Employees898.00
- LocationShilpa Medicare Ltd#12-6-214/A1, Hyderabad Road,RAICHUR 584135IndiaIND
- Phone+91 8 532238704
- Fax+91 8 532238876
- Websitehttps://www.vbshilpa.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Senores Pharmaceuticals Ltd | 5.89bn | 1.02bn | 37.66bn | 194.00 | 36.49 | -- | 28.96 | 6.40 | 22.41 | 22.41 | 130.31 | -- | -- | -- | -- | 30,336,080.00 | -- | -- | -- | -- | 58.73 | -- | 17.48 | -- | -- | 5.94 | -- | -- | 85.64 | -- | 86.17 | -- | -- | -- |
| Innova Captab Ltd | 14.97bn | 1.32bn | 40.36bn | 1.95k | 30.49 | -- | 22.93 | 2.70 | 23.13 | 23.13 | 261.52 | -- | -- | -- | -- | 7,676,703.00 | -- | 10.02 | -- | 15.00 | 36.26 | 27.20 | 8.85 | 8.72 | -- | 12.45 | -- | -- | 15.02 | 27.21 | 35.95 | 35.69 | 109.94 | -- |
| Sun Pharma Advanced Research Co Ltd | 531.36m | -2.68bn | 44.45bn | 316.00 | -- | -- | -- | 83.65 | -8.26 | -8.26 | 1.64 | -- | -- | -- | -- | 1,681,519.00 | -- | -60.53 | -- | -129.98 | 54.57 | 77.17 | -504.20 | -168.34 | -- | -8.82 | -- | -- | -5.00 | -1.35 | 11.55 | -- | -28.16 | -- |
| Zota Health Care Ltd | 4.73bn | -726.58m | 48.48bn | 519.00 | -- | -- | -- | 10.25 | -23.98 | -23.98 | 157.24 | -- | -- | -- | -- | 9,108,992.00 | -- | -7.79 | -- | -10.57 | 57.22 | 42.02 | -15.34 | -8.01 | -- | -3.71 | -- | -- | 62.32 | 25.23 | -293.08 | -- | 49.40 | 0.00 |
| Supriya Lifescience Ltd | 7.35bn | 1.85bn | 57.15bn | 515.00 | 30.81 | -- | 27.05 | 7.77 | 23.05 | 23.05 | 91.47 | -- | -- | -- | -- | 14,280,700.00 | -- | 18.45 | -- | 21.63 | 72.33 | 59.62 | 25.19 | 25.45 | -- | 129.43 | -- | 3.59 | 22.11 | 17.45 | 57.80 | 20.69 | 45.94 | -- |
| F D C Ltd | 20.78bn | 2.17bn | 63.99bn | 6.86k | 29.53 | -- | 23.09 | 3.08 | 13.31 | 13.31 | 127.73 | -- | -- | -- | -- | 3,030,531.00 | -- | 11.35 | -- | 12.96 | 67.92 | 60.85 | 10.43 | 14.75 | -- | 47.92 | -- | 6.34 | 8.50 | 9.42 | -12.59 | 2.15 | 25.37 | -- |
| Shilpa Medicare Ltd | 14.32bn | 1.50bn | 64.84bn | 898.00 | 42.77 | -- | 24.20 | 4.53 | 7.75 | 7.75 | 73.87 | -- | -- | -- | -- | 15,945,910.00 | -- | 2.02 | -- | 2.61 | 70.47 | 60.07 | 10.48 | 5.17 | -- | 4.67 | -- | 9.89 | 11.71 | 7.22 | 145.63 | -12.90 | 16.09 | -- |
| Aarti Pharmalabs Ltd | 19.06bn | 2.40bn | 67.98bn | 2.16k | 28.35 | 3.32 | 20.40 | 3.57 | 26.45 | 26.45 | 210.27 | 225.75 | 0.6309 | 1.39 | 4.22 | 8,812,209.00 | 7.94 | -- | 10.54 | -- | 51.04 | -- | 12.58 | -- | 0.8706 | 9.62 | 0.2435 | -- | 14.17 | -- | 25.59 | -- | -- | -- |
| Akums Drugs and Pharmaceuticals Ltd | 41.08bn | 3.17bn | 72.09bn | 7.54k | 22.74 | 2.29 | 14.94 | 1.76 | 20.71 | 20.71 | 268.25 | 205.66 | 0.8712 | 3.69 | 4.85 | 5,450,531.00 | 6.86 | -- | 8.82 | -- | 41.18 | -- | 7.87 | -- | 3.18 | 4.98 | 0.0277 | -- | -1.44 | -- | 8,481.07 | -- | -- | -- |
| Sudeep Pharma Ltd | 6.17bn | 1.68bn | 74.66bn | -- | 43.37 | -- | 40.65 | 12.11 | 15.24 | 15.24 | 55.94 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 63.01 | -- | 27.56 | -- | -- | 55.99 | -- | -- | 9.40 | -- | 4.19 | -- | -- | -- |
| Blue Jet Healthcare Ltd | 11.79bn | 3.52bn | 76.70bn | 491.00 | 21.76 | 6.11 | 20.53 | 6.50 | 20.32 | 20.32 | 68.01 | 72.39 | 0.8706 | 2.87 | 4.51 | 24,013,560.00 | 26.02 | -- | 31.72 | -- | 54.32 | -- | 29.89 | -- | 3.29 | 78.01 | 0.0162 | -- | 44.74 | -- | 86.38 | -- | -- | -- |
| Strides Pharma Science Ltd | 47.26bn | 5.11bn | 80.71bn | 3.30k | 15.78 | -- | 11.08 | 1.71 | 55.49 | 55.49 | 512.73 | -- | -- | -- | -- | 14,315,680.00 | -- | -0.6014 | -- | -1.09 | 59.34 | 50.33 | 11.23 | -1.06 | -- | 8.50 | -- | -- | 17.36 | 10.65 | 437.22 | 52.50 | 10.08 | -22.16 |
| Marksans Pharma Ltd | 28.03bn | 3.60bn | 84.99bn | 1.35k | 23.57 | -- | 18.52 | 3.03 | 7.96 | 7.96 | 61.92 | -- | -- | -- | -- | 20,780,450.00 | -- | 14.15 | -- | 17.41 | 56.77 | 51.56 | 12.90 | 14.58 | -- | 20.42 | -- | 7.77 | 20.46 | 18.25 | 21.32 | 26.60 | 23.73 | 51.57 |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 89.22bn | 3.76k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 32.29 | -- | 40.74 | -- | 92.07 | -- | 16.78 | -- | -- | -- | -- | 44.59 | 37.80 | 31.10 | 73.77 | 47.62 | -- |
| Procter & Gamble Health Ltd | 13.49bn | 2.93bn | 91.01bn | 1.33k | 31.04 | -- | 28.78 | 6.75 | 176.64 | 176.64 | 811.45 | -- | -- | -- | -- | 10,169,760.00 | -- | -- | -- | -- | 72.49 | -- | 21.76 | -- | -- | 806.81 | -- | -- | -- | -- | -- | -- | -- | -- |
| Sanofi India Ltd | 19.33bn | 3.56bn | 93.48bn | 991.00 | 26.24 | -- | 23.74 | 4.84 | 154.71 | 154.71 | 839.09 | -- | -- | -- | -- | 19,500,500.00 | -- | 22.31 | -- | 31.44 | 51.42 | 54.10 | 18.44 | 21.53 | -- | 321.27 | -- | 132.73 | 0.8567 | -8.10 | -13.96 | -5.41 | -13.65 | 1.99 |
Data as of Feb 13 2026. Currency figures normalised to Shilpa Medicare Ltd's reporting currency: Indian Rupee INR
9.30%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| ICICI Prudential Asset Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2025 | 4.19m | 2.14% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 3.55m | 1.81% |
| Bandhan AMC Ltd.as of 31 Dec 2025 | 2.61m | 1.34% |
| Eastspring Investments (Singapore) Ltd.as of 31 Aug 2024 | 1.59m | 0.81% |
| Ashoka Whiteoak Capital Pte Ltd.as of 30 Jun 2025 | 1.42m | 0.73% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 1.31m | 0.67% |
| Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 Dec 2025 | 1.30m | 0.66% |
| WhiteOak Capital Asset Management Ltd.as of 31 Dec 2025 | 847.78k | 0.43% |
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2025 | 814.92k | 0.42% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 549.84k | 0.28% |
More ▼
Data from 30 Sep 2025 - 15 Jan 2026Source: FactSet Research Systems Inc.
